Less common but more severe side effects include pancreatitis, gastroparesis, bowel obstruction, gallstone attacks, and bile duct blockage
Daniel Drucker [Biomarker April 2023] Can GLP-1/GIP therapies improve long term health outcomes
CJC-1295 with DAC is the long-acting, albumin-binding form with the strongest direct human study data
158,159,160 Recent research shows that hepatocytes release cholesterol and C-X-C motif chemokine ligand 1 (CXCL1), drawing neutrophils from the bone marrow to the injured liver, where they subsequently secrete HGF to enhance hepatocyte proliferation and support liver regeneration
The compounds described here are not drugs, are not intended for human or veterinary use, and are not intended to diagnose, treat, cure, or prevent any condition
For milder symptoms, contact NHS 111 or your GP for guidance